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Abstract
Objectives The human cytomegalovirus (CMV) is
universally distributed among human populations as
one of the most common cause of congenital infection
with an incidence of about 0.15–2.0% in developed
countries. However, controversial data concerning
intrauterine fetal death caused by CMV infection exist. 
Method A case report.
Results In this case report we present a stillbirth in
the 18th week of pregnancy, caused by a maternal sero-
logical and fetal histological congenital CMV infection. 
Conclusion Every attending physician and obstetri-
cian should be aware of the possibility of a primary or
even recurrent congenital CMV infection that could be
a reason for sudden unknown congenital fetal death.
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Introduction
The human cytomegalovirus (CMV) is universally dis-
tributed among human populations [1]. CMV is one of
the most common causes of congenital infections with
an incidence of about 0.15–2.0% in developed coun-
tries [2]. Severe neonatal symptoms of congenital CMV
are more often in infants born to mothers with primary
infection in pregnancy. Here, the typical clinical Wnd-
ings can be found in only about 10–15% of newborns in
mothers with primary CMV infection [3, 4]. These clin-
ical Wndings include intrauterine growth restriction
(IUGR), microcephaly, petechiae, hepatoaplenomega-
lie, chorioretinitis, jaundice, cytopenia and atypical
Wndings with a mortality rate among infants with neo-
natal manifestations of congenital CMV of about 10–
30% [5]. Among infected infants born to mothers with
recurrent infections clinical symptoms are less com-
mon. Most children with congenital CMV born to
mothers with secondary CMV infection are asymptom-
atic at birth. Less than 10% seem to develop postnatal
sequelae. Nevertheless, secondary maternal CMV may
also be a signiWcant cause of severe congenital CMV
disease and in some cases may even cause intrauterine
fetal death [6–10]. However, the role of CMV infection
in fetal death is not fully understood. Studies by Yow
et al. [11], as well as by GriYths and Baboonian [12],
reported about fetal death and spontaneous abortion in
women with CMV infection. Contrast studies by Moyo
et al. [13] and Eskild et al. [14] could not Wnd a causal
relationship. In this report we want to describe a case
of fetal death caused by congenital CMV infection.
Therefore the human cytomegalovirus should stay in
the mind of every attending physician as a cause of
intrauterine fetal death.
Case report
A 37-year-old gravida 3, para 2 woman in the 13th week
of gestation was admitted to our hospital with the inten-
tion to treat an infection with Trichimonas vaginalis. At
the time of introduction she was treated stationary in a
psychiatric hospital for an acute exacerbation of a shico-
aVective psychosis complicated by an alcohol- and
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treatment of the psychosis during pregnancy was possi-
ble (increasing rate of fetal malformation), a medical
indication for an induced abortion was indicated not to
endanger the live of the mother. At that time, the disori-
entated divorced welfare recipient without graduation
released herself from hospital and could not be located
until her 18th week of gestation.
However, a local therapy with clotrimazol for 6 days
was started. During prenatal ultrasound care, an early
intrauterine growth restriction fetus with an omphalozele
was found. After passing the usual preventive medical
checkup including an HIV anti-body test, TPHA test,
cervix smear for Chlamydia trachomatis and usual cer-
vix smear for bacteria (all tests without pathological
Wndings), the patient was introduced again for prenatal
diagnosis after 3 days. Surprisingly, ultrasonic veriWca-
tion demonstrated an intrauterine fetal death in the
18th week of gestation. An initiation to abort the preg-
nancy with misopsostol was started and on the same
day the patient gave stillbirth to a male, growth
restricted, malformated fetus of 400 g. Serologically,
maternal IgM (1:160) and IgG (47.0 AE/ml) antibodies
against CMV were demonstrated, indicating a primary
or a recurrent CMV infection of the mother.
The histological analysis of the placenta showed a
granulocitic villositis and perivillosits with detection of
CMV-inclusions (Fig. 1). The autopsy of the fetus
exposed a generalized cytomegalovirus infection with
immunohistochemical proof of CMV-inclusions in the
lungs (Fig. 2), liver, pancreas, spleen, thymus, thyroid
and kidneys. Besides this, a deformity of the left arm with
radiological absence of the ulna and the radius, as well as
a omphalocele (1.4 £ 0.8 £ 0.6 cm) with exenteration of
parts of the liver and the small intestine was assessed.
Discussion
Congenital cytomegalovirus infection is one of the
most common intrauterine infections in pregnancy.
The prevalence is higher in poor countries and in peo-
ple with low socioeconomic status. In healthy individu-
als an initial (primary) infection is usually clinical
unapparent. The virus turns into a latent state, from
which it can be reactivated due to yet unknown causes,
leading to a recurrent infection.
CMV can lead to congenital infections through
transplacental transmission. Primary infection aVects
0.7–4.1% of seronegative pregnant women and vertical
transmission occurs in 20–40% of these cases [15].
Transmission of recurrent infections to the fetus ranges
from 0.15–3%, depending on the population studied [1].
Although the fetus can be aVected by CMV throughout
the whole pregnancy, the damage is more severe in
infections occurring during the Wrst half of the preg-
nancy [6, 16]. The risk of symptomatic congenital CMV
infection after maternal primary or secondary infection
is quite unknown but it has been suggested to be as high
as 15% after primary and 2% after secondary infection.
Controversial data exist concerning intrauterine
fetal death caused by CMV infection. The rate of intra-
uterine fetal death is not known and the causes of this
phenomenon are largely unknown. Yow et al. [11]
reported a higher rate of spontaneous abortions and
fetal death in women with primary CMV infection
compared to those without an infection. In studies by
GriYths and Baboonian [12], CMV infection was seen
more often in women with fetal death compared to
women with life born children. Therefore, an associa-
tion between maternal CMV infection and fetal death
Fig. 1 CMV-placentitis with immunohistochemical proof of
CMV-inclusions
Fig. 2 Immunohistochemical reaction against CMV antibody
with inclusions in the fetal lung123
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these studies suVer from a limited number of cases with
fetal deaths and that the estimated impact of CMV
infection is uncertain [14]. Eskild et al. [14] could not
Wnd an impact of maternal CMV infection and the risk
of fetal death in a study based on a source population
of nearly 36,000 pregnant women. In another study by
Moyo et al. [13] no increased prevalence of maternal or
fetal CMV infection in over 100 cases compared to
nearly 100 controls was seen.
CMV is a virus that can aVect the fetal organs
throughout the whole pregnancy. The damage seems
to be more severe in infections occurring during the
Wrst half of the pregnancy, while infections in the sec-
ond half would result in reduced morbidity [16]. Vari-
ous ways of transmitting the virus to the fetus have
been suggested, whereas the hematogenious spreading
across the placenta with subsequent infection of pla-
cental and amniotic tissue seems to be the most com-
mon transmission way. As compared to our case
report, where the histological analysis of the placenta
showed a massive CMV-placentitis, Chung-Hua et al.
[17] reported of a higher presence of CMV-DNA in
placentas of cases with fetal death, compared to con-
trols. The virus replicates in the oropharynx and is then
carried through the fetal circulation. A large spectrum
of cells in the fetus is infected by cytomegalovirus. The
major target organs of CMV in the fetus are the lungs,
pancreas, kidneys and the liver [3].
In our case, maternal serological data at the time of
diagnosis of fetal death showed IgG and IgM antibod-
ies against CMV, indicating a primary or a recurrent
infection. Unfortunately, no earlier serum samples of
the patient were available to determine the exact time
point of infection. Although it is generally accepted
that primary maternal CMV infection in pregnancy
leads to a more severe infection of the fetus, there is
increasing evidence that secondary or reactivated
maternal CMV infection may also be a signiWcant
cause of severe congenital CMV disease and in some
cases also cause intrauterine fetal death [5–10]. In our
case, the histological analysis of the placenta showed a
massive CMV-placentitis and the autopsy report of the
dead fetus exposed a massive generalized cytomegalo-
virus infection of the fetus, including immunohisto-
chemical proof of CMV-inclusions in the lungs, liver,
pancreas, spleen, thymus, thyroid and kidneys. These
Wndings make the congenital CMV infection as the
cause of the fetal death in our case very likely.
In conclusion, every attending physician and obste-
trician should be aware of the possibility of a primary
or even recurrent congenital CMV infection that
could be a reason for sudden unknown congenital
fetal death. The best perspective would be a quick
development of a safe and eVective vaccine against
CMV. As no vaccination is available yet, besides an
education of women to prevent CMV acquisition [12],
a safe and eVective therapy and prevention of congenital
CMV infection is still not possible. Recently, treatment
of pregnant women with CMV-speciWc hyperim-
mune globuline showed very promising results in the
prophylaxis of a congenital CMV infection [18].
However, this treatment option is being still under
investigation.
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